Insider Transactions in Q3 2025 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
24,585
-4.96%
|
$1,499,685
$61.49 P/Share
|
|
Sep 12
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,585
+5.67%
|
$934,230
$38.1 P/Share
|
|
Sep 11
2025
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
15,705
-22.84%
|
$926,595
$59.5 P/Share
|
|
Sep 11
2025
|
Emma Reeve |
BUY
Exercise of conversion of derivative security
|
Direct |
10,837
+19.97%
|
$314,273
$29.66 P/Share
|
|
Sep 11
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
22,664
-6.4%
|
$1,382,504
$61.0 P/Share
|
|
Sep 11
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,664
+5.74%
|
$861,232
$38.1 P/Share
|
|
Sep 09
2025
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
12,000
-41.59%
|
$696,000
$58.34 P/Share
|
|
Sep 09
2025
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+29.38%
|
$360,000
$30.86 P/Share
|
|
Sep 08
2025
|
Eric Pauwels CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
39,850
-6.87%
|
$2,231,600
$56.9 P/Share
|
|
Sep 08
2025
|
Eric Pauwels CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
39,850
+6.18%
|
$677,450
$17.83 P/Share
|
|
Aug 28
2025
|
Allan Steven Jacobson |
SELL
Open market or private sale
|
Direct |
1,667
-8.72%
|
$83,350
$50.15 P/Share
|
|
Aug 15
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
2,813
-2.64%
|
$135,024
$48.58 P/Share
|
|
Aug 15
2025
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+2.57%
|
$70,325
$25.69 P/Share
|
|
Aug 05
2025
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,739
-3.08%
|
$547,689
$51.74 P/Share
|
|
Aug 01
2025
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+17.71%
|
-
|
|
Jul 15
2025
|
Pierre Gravier CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,516
-3.38%
|
$123,284
$49.46 P/Share
|